Niraxx Light Therapeutics Announces New Study Validating Personalized Light Therapy

BLOG “The joint study has confirmed that personalized PBM dosing is key to MDD treatment.” Post Date December 20, 2021 Share

BLOG “The joint study has confirmed that personalized PBM dosing is key to MDD treatment.” Post Date December 20, 2021 Share
We work with world-class research institutions to advance our science. Our partners include Harvard University and Mass General Hospital (MGH). MGH Psychiatry has consistently been ranked #1 in US News & World Report.
Niraxx products are currently under development. Availability and indications may vary by jurisdiction and regulatory authorization status.
5151 California Ave. Suite 100
Irvine, CA 92617
Copyright © 2016-2026 Niraxx, Inc. All Rights Reserved